183 related articles for article (PubMed ID: 23824571)
1. Lymph node metastasis is mediated by suppressor of cytokine signaling-3 in gastric cancer.
Deng J; Jiao X; Liu H; Wu L; Zhang R; Wang B; Pan Y; Hao X; Liang H
Tumour Biol; 2013 Dec; 34(6):3627-36. PubMed ID: 23824571
[TBL] [Abstract][Full Text] [Related]
2. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
3. STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer.
Deng JY; Sun D; Liu XY; Pan Y; Liang H
World J Gastroenterol; 2010 Nov; 16(42):5380-7. PubMed ID: 21072904
[TBL] [Abstract][Full Text] [Related]
4. Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer.
Xu W; Fu J; Wu H; Sun W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S311-S318. PubMed ID: 29970682
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.
Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of IGFBP7 was a poor prognosis predictor for gastric cancer patients.
Liu L; Yang Z; Zhang W; Yan B; Gu Q; Jiao J; Yue X
Tumour Biol; 2014 Sep; 35(9):8875-81. PubMed ID: 24894674
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of SOCS-3 mRNA in breast cancer with lymph node metastasis.
Nakagawa T; Iida S; Osanai T; Uetake H; Aruga T; Toriya Y; Takagi Y; Kawachi H; Sugihara K
Oncol Rep; 2008 Jan; 19(1):33-9. PubMed ID: 18097573
[TBL] [Abstract][Full Text] [Related]
8. STAT3 is associated with lymph node metastasis in gastric cancer.
Deng J; Liang H; Zhang R; Sun D; Pan Y; Liu Y; Zhang L; Hao X
Tumour Biol; 2013 Oct; 34(5):2791-800. PubMed ID: 23824569
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in Helicobacter pylori infection: a novel mechanism.
Lee JS; Paek NS; Kwon OS; Hahm KB
J Gastroenterol Hepatol; 2010 Jan; 25(1):194-202. PubMed ID: 20136974
[TBL] [Abstract][Full Text] [Related]
10. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer.
Guo W; Li W; Yuan L; Mei X; Hu W
Med Sci Monit; 2019 Dec; 25():10122-10128. PubMed ID: 31884511
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer.
Singh N; Hussain S; Bharadwaj M; Kakkar N; Singh SK; Sobti RC
J Recept Signal Transduct Res; 2012 Dec; 32(6):321-7. PubMed ID: 23134344
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells.
Souma Y; Nishida T; Serada S; Iwahori K; Takahashi T; Fujimoto M; Ripley B; Nakajima K; Miyazaki Y; Mori M; Doki Y; Sawa Y; Naka T
Int J Cancer; 2012 Sep; 131(6):1287-96. PubMed ID: 22095154
[TBL] [Abstract][Full Text] [Related]
14. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
Isomoto H; Mott JL; Kobayashi S; Werneburg NW; Bronk SF; Haan S; Gores GJ
Gastroenterology; 2007 Jan; 132(1):384-96. PubMed ID: 17241887
[TBL] [Abstract][Full Text] [Related]
15. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H
Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
[TBL] [Abstract][Full Text] [Related]
19. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
20. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
